Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

AbbVie Biotech Ventures

Status
ACTIVE
Global HQ
Chicago, United States
Countries of investment
  • USA
Investment stages
  • Seed
Industries
  • Pharmaceuticals
  • Biotechnology
  • HealthCare
About
AbbVie is a global biopharmaceutical company dedicated to developing innovative therapies for serious diseases, striving to impact lives through advanced medicines in key therapeutic areas.
Min check size
$5M
Max check size
$75M
Fund size
NPS

Investment Thesis

AbbVie Biotech Ventures aims to identify and support highpotential biotech and pharmaceutical companies that can contribute to AbbVies strategic goals and overall mission. The firm looks for investments in companies with promising technologies and therapeutic approaches that address significant medical needs. The focus is on advancing innovations that complement AbbVies existing portfolio and leverage its expertise in biopharmaceutical development.
Lead investor
Co Invest
Number of exits
Preferred contact method

AbbVie Biotech Ventures Contacts Information

Primary contact

Secondary contact

Portfolio

AbbVie

AbbVie Inc

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp